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ABSTRACT 
Determinants of Head and Neck Cancer Survival in Nevada for 1995-2008 
by 
Xiao Li 
Dr. Paulo Pinheiro, Examination Committee Chair 
Assistant Professor of Epidemiology and Biostatistics 
School of Community Health Sciences 
University of Nevada, Las Vegas 
 
Head and neck cancer (HNC), also known as oral cavity and pharyngeal cancer, 
comprises a group of cancers that arise in the head or neck region, such as the nasal 
cavity, sinuses, lips, mouth, salivary glands, and pharynx. Use of tobacco, alcohol, or a 
combination of the two, are major risk factors for head and neck cancer.  Approximately 
75% of oral cancers are attributable to smoking and/or alcohol consumption. More 
recently, the human papilloma virus (HPV) has also been associated with the 
development of head and neck cancer. 
The objective of the present study is to investigate head and neck cancer survival in 
Nevada and its potential determinants utilizing Nevada Central Cancer Registry data 
between 1995 and 2008. The life table method was used to calculate age-adjusted 5-year 
survival rates. The Kaplan-Meier method and Cox regression were adopted to identify 
significant determinants of head and neck cancer survival in Nevada. 
A total of 2,522 new cases of head and neck cancer in Nevada were analyzed. Age, 
race/ethnicity, civil status, insurance status, site, and stage of diagnosis are all significant 
determinants for head and neck cancer survival in Nevada. The Surveillance, 
 iv 
Epidemiology, and End Results (SEER) Program reported a significant survival disparity 
between whites and blacks in 2013 for HNC. A significant disparity in survival, due to 
race, was observed in Nevada. Blacks tend to have the worst survival outcome after 
adjusting for select covariates (HR=1.35, 95% CI: 1.04-1.75), even though black males in 
Nevada were found to have a better 5-year overall age-adjusted survival rate (38.2%) 
than the national average (25.7%). The findings from this study also suggested a 
geographic disparity in survival between Northern (HR=0.89, 95% CI: 0.77-1.02) and 
Southern Nevada, possibly due to limited quality healthcare resources, different lifestyle 
factors, or inadequate access to care, in the south. The present study shows that insured 
individuals with private insurance or Medicare have significantly better chances at 
survival, after diagnosis of head and neck cancer, than uninsured individuals (HR=1.45, 
95% CI=1.17-1.80), with a difference as much as half.  Specific public health strategies, 
such as increasing oral screenings and persuading public officials to include dental care 
coverage as part of health insurance, are necessary to improve head and neck cancer 
survival and to diminish survival disparities in Nevada. 
  
 v 
ACKNOWLEDGEMENTS 
 
I would like to thank Dr. Pinheiro for pushing and guiding me in completing this thesis as 
well as for being my chairperson. You are easily the most challenging and knowledgeable 
epidemiology professor on campus. 
Also, I would like to thank my committee members, Dr. Buttner, Dr. Chino, and Dr. 
Kingsley, who are all brilliant and distinguished in their own rights; along with agreeing 
to be in my committee and guiding this thesis to completion with your input. That’s why 
I chose each of you to be on my committee to begin with. Dr. Kingsley, I will see you for 
another four years at the SODM. 
Thanks are also in order to Fred Jin and Ariana Goertz for your friendships, proofing my 
thesis, and passing time. To Fidelis Uzoma Enyinnaya, for having a name harder to 
pronounce than mine, and for your friendship from UNLV to NSC. 
Lastly, thanks to my family for their support; especially, to my brother John, for always 
being my endless cheerleader even when I don’t know what I am doing myself. Shannon 
Lee for being patient and firm with me. To myself, for working and paying for this 
degree, instead of spending it on a nice car, or vacation on a tropical island holding a 
fruity drink with a tiny umbrella in one hand.  
 vi 
TABLE OF CONTENTS 
 
ABSTRACT………………………………………..………………….…………..…..iii 
ACKNOWLEDGEMENTS…………………………………………………………....v 
LIST OF TABLES…………………………………………………….……………….viii 
LIST OF FIGURES…………………………………………………….…….…….….ix 
CHAPTER 1 INTRODUCTION………….…………..…….………….……………..1 
Background and Significance…………………………………….….......…….2 
  Epidemiology…………….………………...………...……..........…….2 
  Major Risk Factors………...…………….…….………....….…..…….4 
  Diagnosis…………………………………………………….……...….6 
 Treatment and Prevention……………………………………….......…7 
  Determinants of Cancer Survival………………………………….…...8 
  Relevance to Public Health………………………..………………..…10 
Purpose of the Study……………………………………………………......…12 
 Research Question and Hypotheses…………………………………...........…12 
CHAPTER 2 METHODOLOGY……………………………………………..………14 
Data Collection…………………………………….……………………..……14 
 Data Sources…………………………………………………………..14 
 Study Population……………………………………………….….…..14 
 Study Design and Institutional Review Board (IRB)…………....……15 
 Head and Neck Cancer Classification………………………….……...15 
 Stage of Diagnosis Classification……………………………….……..15 
 Demographics…………………………………………………….…...16 
 Head and Neck Cancer Survival Time……………………………..….17 
Statistical Analysis……………………………………………………….....…17 
CHAPTER 3 RESULTS………………………………………………………...….…19 
Patient Characteristics………………..………………………….…...……......19 
Univariate Analysis……………………………………………….…..……….19 
  Survival Rates for Each Category of the Predictor Variables……....…19 
 vii 
  Kaplan-Meier Method……………………….………..……....…….…21 
Multivariate analysis…………………………………….………………......…22 
 Age…………………………………………………………….………22 
 Gender……………………………………………………….…….…..23 
 Site…………………………………………………………….…..…..23 
 Race/Ethnicity………………………………………………………….23 
 Insurance Status…………………………………………….…………23 
 Stage…………………………………………………………..……….23 
 Civil Status……………………………………….………………..…..24 
 Geographic Region……………………………….………………..…..24 
CHAPTER 4 DISCUSSION…………………………………………….................…25 
 Summary of Findings………………………………………….………………25 
Limitations…………………………………………………..…………..…..…31 
 Conclusions………………………………………..……………..…....….……32 
APPENDIX A. INSTITUTIONAL REVIEW BOARD APPROVAL...…….….….…35 
APPENDIX B. CHARACTERISTICS AMONG 2,522 PATIENTS WITH HEAD 
AND NECK CANCER………………………………………………..………36 
APPENDIX C. KAPLAN-MEIER OVERALL SURVIVAL BY CIVIL STATUS, 
1995-2008………………………………………………………..……..……..37 
APPENDIX D. COX HAZARD RATIOS (HR), HEAD AND NECK CANCER 
SURVIVAL, IN NEVADA, 1995-2008……………………….……………..38 
REFERENCES………………...……............................................................................39 
VITA………………………………………….…………………...……….…….……43 
  
 viii 
LIST OF TABLES 
 
Table 1: 5-year overall age-adjusted survival rate for males and females combined 
 in Nevada, 1995-2008..………………………………………………………19 
Table 2: 5-year overall age-adjusted survival rate for males and females combined, 
SEER, 1995-2008...……………………………………………………….......20 
Table 3: 5-year overall age-adjusted survival rate for males in Nevada, 1995-2008....20 
Table 4: 5-year overall age-adjusted survival rate for males, SEER, 1995-2008….....21  
 ix 
LIST OF FIGURES 
 
Figure 1: Kaplan-Meier overall survival by race, 1995-2008…………….…....……..22  
1 
 
CHAPTER 1 
INTRODUCTION 
Head and neck cancer (HNC), also known as oral pharyngeal cancer, includes cancers of 
the lip, oral cavity, oropharynx, hypopharynx, tonsil, salivary glands, nasopharynx, nose, 
paranasal sinus, and middle ear (Piccirillo, Costas, & Reichman, 2007). They are usually 
grouped together by epidemiologists based on their anatomical sites. The International 
Classification of Diseases (ICD, 10th revision) classifies head and neck cancer into 
malignant neoplasms of the lip, oral cavity (tongue, major salivary glands, gum, floor of 
the mouth, other parts of the mouth), and pharynx (oropharynx, nasopharynx, and 
hypopharynx).  
The National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) 
Program is the only comprehensive population-based cancer registry that includes stage 
at diagnosis and patient survival data (SEER, 2014). It covers approximately 28% of the 
United States. SEER 17 areas are composed of SEER 13 plus Greater California, 
Kentucky, Louisiana, and New Jersey (SEER, 2014). The SEER registry is generally 
considered a good representation of the entire U.S. population (Reid et al., 2001). 
The most frequent sites for head and neck cancer are tongue (21%), gum and other mouth 
sites (15%), tonsil (11%), and salivary glands (10%) [Piccirillo et al., 2007]. Almost all 
head and neck cancers begin as squamous cells that cover the moist mucosal surfaces of 
the oral cavity (National Cancer Institute [NCI], 2008). Globally, over 90% of head and 
neck cancers are squamous cell carcinomas (Johnson et al., 2011). However, malignant 
neoplasms of the salivary glands have mixed cell type origins. They are more likely to be 
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adenocarcinomas, which start in gland cells, rather than squamous cell carcinomas. As a 
result, salivary glands are often not included in head and neck cancer studies (Pulte, & 
Brenner, 2010; Shibosky, Schmidt, & Jordan, 2007). In addition, malignant neoplasms of 
the lip are not usually included either, due to their separate risk factors. The major risk 
factor for lip cancer is sun exposure, which is different from the epidemiologic risk 
factors associated with head and neck cancer (Piccirillo et al., 2007). Therefore, 
malignant neoplasms of the salivary glands and lip were excluded from the present study. 
Background and Significance 
Epidemiology 
Head and neck cancer ranks as the sixth most common cancer in the world, probably due 
to heavy tobacco and alcohol consumption in the developing countries (Saman, 2012). 
Global figures show an estimated 482,300 new cases and 406,800 deaths in 2008; men 
are three times more likely to be diagnosed with head and neck cancer than women 
(Jemal et al., 2011). However, these figures include both adenocarcinomas (cancer 
originating from glands) and squamous cell carcinomas (cancer originating from 
epithelial cells) [Jemal et al., 2011]. The World Health Organization’s International 
Agency for Research on Cancer show oral cavity cancer mortality rates to be: 66.9% in 
Asia, 16.6% in Europe, 0.7% in Oceania, 6.9% in Africa, 5.5% in Latin America & 
Caribbean, and 3.4% in North America (Globocan, 2012). 
Head and neck cancer accounts for 2.3% of cancers in the United States (Saman, 2012). 
SEER incidence rates of the top 15 cancers, for 1992-2007, show that head and neck 
cancer is the eighth leading cancer for men and fourteenth leading cancer for women in 
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terms of incidence (Kohler, 2011). According to SEER data, the prevalence of head and 
neck cancer in the United States was 275,193 in 2012, with 41,380 new cases and 7,890 
deaths in 2013 (SEER, 2013; Siegel, Naishadham, & Jemal, 2013). Head and neck cancer 
has an age-adjusted incidence rate of 10.8 per 100,000 men and women each year with a 
median diagnosis of 62 years of age (Howlader, 2013). Head and neck cancer is common 
in people 60 years of age and over; but, incidence has increased for people under 40 years 
of age, due to changing risk factors (Laronde, Hislop, Elwood, & Rosin, 2008). The 
lifetime risk of being diagnosed with head and neck cancer is 1 in 93 for men and women 
(Howlader et al., 2013). 
Overall, head and neck cancer incidence in the United States has substantially decreased 
over the past few decades. The National Cancer Institute (NCI) estimated that three out of 
four people diagnosed with head and neck cancer have used tobacco, alcohol, or both 
(NCI, 2008). The declines are largely credited to a decrease in smoking prevalence 
beginning in the 1970s as tobacco use decreased in the United States as a result of public 
health efforts to reduce consumption of smoking since the Surgeon General’s Report in 
1964 (Kim, King, & Agulnik, 2010). 
According to SEER data, between 1975 and 2007, head and neck cancer is on the top 
fifteen leading causes of cancer deaths in men, while absent from the same list for women 
(Kohler et al., 2011). The mortality rate for head and neck cancer has been decreasing for 
the last 30 years. The death rates were decreasing by 1.3% for men and 2.2% for women 
on an annual basis from 2005 to 2008 (American Cancer Society, 2013). However, the 
overall 5-year survival rate is less than 50% (Mehanna, West, Nutting, & Paleri, 2010). 
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Major Risk Factors 
Many risk factors for causing head and neck cancer have been identified. The most 
common ones include tobacco, betel quid, alcohol, Human papillomavirus infection, poor 
diet, poor oral hygiene and dentition. 
1. Substance use 
The single most important risk factor for head and neck cancer is tobacco use. Smokers 
have a 5-25 fold risk of developing head and neck cancer compared to nonsmokers based 
on frequency, duration, and extent of smoking (Mehanna et al., 2010). In South and 
Southeast Asia, tobacco is popularly consumed in the form of betel quid, which is 
primarily composed of piper betel leaves rolled with areca nuts, tobacco, and other 
additives (Johnson et al., 2011). Tobacco use has been labelled as the world’s most 
avoidable cause of cancer by the World Health Organization (Petersen, 2008). Heavy 
alcohol drinking is an independent risk factor for causing HNC even though there is no 
current evidence to suggest differences in risk due to different types of alcohol 
consumption (Kim et al., 2010). It is reported that never smokers who drink three or more 
alcoholic beverages per day had almost twice the risk for HNC as never drinkers 
(Hashibe et al., 2007). Alcohol and tobacco have a multiplicative effect. A dose-response 
relationship exists in both alcohol and tobacco consumption where the risk for head and 
neck cancer increased along with consumption (Mehanna et al., 2010). A study found that 
heavy smokers and heavy drinkers are 20.7 and 4.9 times more likely to have HNC than 
those who don’t smoke and drink, but a combination of the two, elevates the risk to 48 
times (Saman, 2012). Head and neck cancer due to alcohol and smoking exposure have a 
population attributable risk of 80% for men and 61% for women (Petersen, 2008). 
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2. Human papillomavirus (HPV) 
Historically, tobacco and alcohol are the most important risk factors for head and neck 
cancers (Saman, 2012). However, oral HPV infection is now linked with an increasing 
proportion of head and neck cancer. Studies have shown that HPV-related head and neck 
cancer is more frequent in patients who do not smoke or drink (Argiris, Karamouzis, 
Raben, & Ferris, 2008). Although there are over 100 subtypes of HPV, only two 
subtypes, 16 and 18, far exceed the detection rate compared to other subtypes (Mehanna 
et al., 2010). HPV 16 has been singled out as the most common subtype found in head 
and neck cancer (Mehanna et al., 2010). HPV strain subtype 16 has been identified as the 
main causal factor in HNC with HPV16 DNA detected in up to 72% of head and neck 
cancers (Argiris et al., 2008). Mehanna (2010) reported that up to 90% of head and neck 
cancer carcinomas have identified HPV-16 DNA in them. While a recent multi-state 
study estimated that 70% of head and neck cancer is caused by HPV infection 
(Chaturvedi et al., 2011).   
HPV has been implicated as a significant risk factor for head and neck cancer. HPV-
related head and neck cancer occurs most commonly in the tonsils and oropharynx and 
least commonly in the oral cavity. HPV-positive head and neck cancer has increased from 
16.3% in 1984 to 72.7% in 2004, partially due to increased oral sex and oral HPV 
exposure (Chaturvedi et al., 2011). A SEER analysis from 1973-2001 showed an increase 
of incidence in oral tongue, base of tongue, and tonsil cancers by 2.1%, 1.7%, and 3.9% 
in people aged 20-44 (Mehanna et al., 2010). HPV-negative head and neck cancer has 
declined, paralleling the decline in smoking in the United States (Chaturvedi et al., 2011). 
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Although smoking has been on the decline in the United States, the gains realized have 
been somewhat countered by a rise in head and neck cancer due to the HPV epidemic.  
3. Others 
Eating diets rich in vegetables, fruits, and vitamin C have been shown to have a 
protective effect against head and neck cancer (Laronde et al., 2008). High intake of meat 
and processed meat products are associated with higher risk for head and neck cancer. 
Poor oral hygiene and poor dentition are risk factors as well. It is believed that improper 
dentures or tooth repair causes tissue irritation that facilitates exposure to carcinogens. 
Oral microbes in alcohol drinkers convert alcohol into acetaldehyde, a carcinogen that 
increases risk for head and neck cancer. Lower social economic status due to occupation, 
income, or education is also a significant risk factor for head and neck cancer 
(Warnakulasuriya, 2008). 
Diagnosis 
Symptoms of head and neck cancer include a sore in the lip or mouth that doesn’t heal, 
difficulty when swallowing, bleeding in the mouth, loose teeth, numbness in the lower lip 
and chin, to having white or red patches in the lips and mouth (NCI, 2008). The red 
patches are called erythroplakia while the white patches are called leukoplakia. They are 
precancerous lesions and are clinical terms with no association to histopathology 
(Mehanna et al., 2010). A biopsy of a tissue sample remains the gold standard for 
confirmation of malignant cells (NCI, 2008). A biopsy and histopathological exam are 
always necessary to establish a diagnosis of oral cancer (Bagan, Sarrion, & Jimenez, 
2010). 
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Treatment and Prevention 
Most head and neck cancers are diagnosed at late stage because symptoms are hard to 
notice. Stage at diagnosis also determines what treatment options are available for 
treating the patient (Shiboski et al., 2007).This contributes to a poor overall survival rate 
of 40-50% (Mehanna et al., 2010). It is reported that survival rate can be improved by 80-
90% if head and neck cancer is detected at the early stage (Bagan et al., 2010). Treatment 
options for head and neck cancer are surgery, radiotherapy, chemotherapy, targeted 
therapy, or a combination of these depending on the stage at diagnosis (NCI, 2008). 
Radiotherapy and surgery are the most common treatment choices (Mehanna et al., 
2010). Early stage cancers are treated with surgery or radiotherapy while more advanced 
stages are treated with surgery and chemoradiotherapy (Mehanna et al., 2010). It is 
estimated that one third of HNC patients have stage I (localized) or stage II (regional) 
cancer (Argiris et al., 2008). Surgery and radiation are used to cure these patients with a 
success rate of up to 90% for stage I patients and up to 70% for stage II presenting 
individuals (Argiris et al., 2008). Efficacy between surgery and radiation treatment is 
roughly equal. However, surgery is preferred over radiation treatment to avoid its more 
toxic cellular effects. Medical technology with robotic surgery and carbon dioxide lasers 
under microscope guidance has increased organ preservation during surgery. Two drugs 
used in chemotherapy, Cisplatin and Cetuximab, when used in combination with 
radiation were shown to increase overall survival and tumor control for later stages 
(Mehanna et al., 2010). However, more radical treatments decrease the quality of life for 
patients. 
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Literature reports that HPV-positive tumors are more responsive to radiation, 
chemotherapy, or both, than HPV-negative tumors (Argiris et al., 2008). The efficacy of 
HPV vaccination against cervical cancer shows potential prevention for head and neck 
cancer as well (Argiris et al., 2008). The FDA approved a vaccine against HPV subtypes 
6, 11, 16, and 18 for both males and females between 9-26 years of age. It is believed that 
the vaccination will benefit head and neck cancer even though the vaccine was initially 
made to guard against genital warts and cervical cancer (Mehanna et al., 2010).  
Determinants of Cancer Survival 
Risk factors that are significantly associated with the development of head and neck 
cancer may not be significant determinants of survival for head and neck cancer, because 
survival determinants and risk factors for head and neck cancer are disparate entities for 
pathogenesis of head and neck cancer. Also information on most risk factors for head and 
neck cancer are not collected by the majority of cancer registries. Therefore, the majority 
of cancer research focuses on a variety of available variables, such as age, gender, 
race/ethnicity, stage at diagnosis, treatment, insurance status, civil status, and geographic 
location. However, there are no set prognostic variables that researchers can agree on as 
being the definitive variables to independently predict survival.  
1. Stage of diagnosis 
Stage at diagnosis is the most important determinant of survival for most cancers, 
including head and neck cancer. Head and neck cancer has a successful cure rate of as 
high as 90% if it is diagnosed in the early stages (Bagan et al., 2010). The sooner an 
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individual is diagnosed and treated for head and neck cancer, the better their chances of 
attaining a high cure rate and an increased survival outcome.  
A strong correlation between stage of diagnosis and relative survival has been well 
established (Piccirillo, Costas, & Reichman, 2007). SEER showed that 31% of cases were 
diagnosed at localized stage with a 5-year survival rate of 82.7% while 47% of cases 
were diagnosed at regional stage with a 5-year survival rate of 59.2% (Howlader et al., 
2013). 
2. Race 
Literature has shown that there are significant disparities in survival between blacks than 
whites in the United States (Saman, 2012). The 5-year relative survival rates for white 
men and women were 63.6% and 64.6% while those for black men and women were 
38.6% and 53.0%, respectively (Howlader et al., 2013). There are various reasons 
proposed for these differences between racial groups. They range from lower educational 
attainment, social economic status, occupational status, access to care, and likelihood of 
being insured, to more advanced stages at time of diagnosis (Ragin et al., 2010). 
Minorities who are associated with lower socioeconomic status and less insurance 
choices are also presented with less preventative and treatment options accessible to 
them. 
3. Others  
Health insurance status has been found to impact the stage at diagnosis and survival 
(Saman, 2012). A study by Kwok (2010) found that Medicaid and uninsured patients 
were three times more likely to present with advanced stages of head and neck cancer 
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(stage III and IV) than private insurance or Medicare. Individuals without insurance or 
had Medicaid were found to have up to 50% lower survival (HR=1.50, 95% CI=1.07-
2.11) than individuals with private insurance. Married individuals have also been shown 
to have better survival outcomes due to better quality of life that leads to a protective 
effect. Married individuals and individuals living together had better survival and lower 
mortality rates than divorced individuals, or those not living together (De Graeff et al., 
2000). The better survival is attributed to better health habits and social support related to 
marriage. 
Researchers have been looking at various independent variables that could be used as 
prognostic factors for head and neck cancer survival time. By finding strong and 
independent indicators for survival time, clinicians and health professionals can lower 
disparities in the survival time of diseased patients, and improve survival rates of 
individuals by targeting individuals known to have lower survival outcomes through 
education, screening, and early diagnosis of patients.  
Relevance to Public Health 
Head and neck cancer has a relatively low incidence and low mortality rate in the United 
Sates. However, the gains seen in smoking cessation through the decades and a lowering 
in head and neck cancer incidence has been offset by increases in HPV-related head and 
neck cancer. While, there is no definitive exact cause for head and neck cancer, the major 
risk factors are preventable. Smoking and alcohol remain the largest risk factors for head 
and neck cancer with socioeconomic status being a contributing factor. 
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Public health should strive to mediate these risk factors as much as possible. Early 
diagnosis, treatment, and prevention of head and neck cancer lead to higher survival 
rates. Advanced treatment usually requires surgery, radiotherapy and chemotherapy, or a 
combination of all three which also tends to lower the quality of life for affected patients. 
The differences between incidence rates for race are minor but the mortality rates 
between whites and blacks show a significant disparity. From 2002-2006, the mortality 
rate for black men was 6.5 per 100,000 versus 3.7 per 100,000 for white men with head 
and neck cancer (Ragin, Langevin, Marzouk, Grandis, & Taioli, 2011). 
Other potential disparities such as insurance status have been found to lead to late stage 
diagnosis and lower survival (Kwok et al., 2010). To provide better head and neck cancer 
outcomes for all segments of the population, public health should enhance programs that 
encourage smoking and alcohol cessation in low income areas, promoting HPV 
vaccination, and practicing safe oral sex in young adults, as well as lobbying for policies 
that result in healthier outcomes for all, by increasing access to care, screenings, and oral 
health insurance. 
In Nevada, head and neck cancer survival outcomes have never been studied. 
Traditionally, Nevada has low access to healthcare and poor social service programs, due 
to the lack of a state income tax as well as low business tax rates, which limit adequate 
public social investments in Nevada. The Centers for Disease Control & Prevention 
(CDC; 2014) Health of the United States 2012 report ranks Nevada as the second state 
with the most uninsured persons in 2008-2011. In addition, Nevada ranks eighteen for 
having the lowest number of doctors per 10,000 people. This retrospective cohort study 
will look for differences and disparities in outcome by examining the determinants of 
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head and neck cancer survival in Nevada utilizing data from the Nevada Central Cancer 
Registry (NCCR) for years 1995-2008. 
Purpose of the Study 
To understand the disparities in head and neck cancer survival in Nevada and compare 
with the national trends, the objectives of the present study are (1) to calculate age-
adjusted 5-year survival rates of head and neck cancer in Nevada by race/ethnicity and 
(2) to identify determinants of head and neck cancer survival in Nevada. 
Research Question and Hypotheses 
Research Question:  
What are the determinants of survival for patients with head and neck cancer in Nevada? 
Hypothesis 1: Gender 
H0: There is no association between head and neck cancer survival and gender. 
HA: There is an association between head and neck cancer survival and gender. 
HA1: Women have better head and neck cancer survival than men. 
Hypothesis 2: Race 
H0: There is no association between head and neck cancer survival and race. 
HA: There is an association between head and neck cancer survival and race. 
HA1: Whites have higher head and neck cancer survival than blacks. 
Hypothesis 3: Insurance Status 
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H0: There is no association between head and neck cancer survival and insurance status. 
HA: There is an association between head and neck cancer survival and insurance status. 
HA1: Having insurance will result in higher head and neck cancer survival than people 
without insurance. 
Hypothesis 4: Civil status 
H0: There is no association between head and neck cancer survival and civil status. 
HA: There is an association between head and neck cancer survival and civil status. 
HA1: Married individuals have higher head and neck cancer survival than single 
individuals. 
Hypothesis 5: Geographic Region 
H0: There is no association between head and neck cancer survival and geographic 
region. 
HA: There is an association between head and neck cancer survival and geographic 
region. 
HA1: Northern Nevada will have higher head and neck cancer survival than Southern 
Nevada. 
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CHAPTER 2 
METHODOLOGY 
Data Collection 
Data Sources 
Data were obtained from the Nevada Central Cancer Registry (NCCR). NCCR is a 
population based registry that collects data on all patients diagnosed with cancer in the 
state of Nevada. NCCR is administered through the Office of Public Health Informatics 
and Epidemiology of the Department of Health and Human Services Nevada Division of 
Public and Behavioral Health. NCCR is part of the National Program of Cancer 
Registries (NPCR) which is administered by the Centers for Disease Control and 
Prevention (CDC). The data obtained from the NCCR meet the completeness and quality 
standards set by NPCR and the North American Association for Central Cancer 
Registries (NAACCR) for 2000-2006 and 2008. Data were obtained from the National 
Cancer Institute’s SEER Program to generate survival tables. SEER is used as the 
representative national population when comparing to Nevada in this study. 
Study Population 
The study population is patients diagnosed with head and neck cancer from 1995 to 2008 
and registered in the NCCR. The total patient cases in the database were initially 3,091. 
Among them, 9 cases were excluded in the age range of 0-14 years because head and 
neck cancer is extremely rare in ages younger than 15 years. One case was excluded due 
to unknown gender. The subsite categories of lips (n=172) and salivary glands (n=336) 
were excluded. An additional 51 cases were excluded due to incomplete data on survival 
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time. After exclusions, the sample size was reduced to 2,522 cases that made up our 
analytical file.  
Study Design and Institutional Review Board (IRB) 
The study design is a retrospective cohort study using secondary de-identified cancer 
registry data. IRB exempt approval was granted for the study of existing data by the 
Office of Research Integrity at the University of Nevada Las Vegas on July 19, 2013. 
Head and Neck Cancer Classification 
Head and neck cancer site topography and morphology variables were coded with the 
SEER site recodes for International Classification of Disease for Oncology, Third 
Edition, morphology codes C000-C148, and histology codes 8000-9990. The site 
category variables were classified using the following sub sites: tongue (C019-C029), 
floor of mouth (C040-C049), gums (C030-C039, C050-C059, C060-C069), nasopharynx 
(C110-C119), tonsils (C090-C099), oropharynx (C100-C109), hypopharynx (C129, 
C130—C139), and other oral cavity and pharynx (C140, C142-C148). 
Stage of Diagnosis Classification 
Both TNM and SEER historic staging are available in the NCCR dataset. Considering the 
completeness and reliability of the data, SEER historic staging was used in the present 
study. SEER is a summary staging system used for all types of cancers. SEER staging 
was classified as localized, regional, distant, or unknown. Localized refers to cancer that 
is limited to the organ it originated from. Regional refers to cancer that has spread from 
the primary site to nearby tissues, nodes, or organs. Distant refers to cancer that has 
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spread from the primary site to distant tissues, nodes, or organs. Unknown refers to 
cancer that was not assigned a stage due to various reasons. 
Demographics  
Demographic variables included gender, geographical location, race/ethnicity, insurance 
status, age at diagnosis, and civil status. Gender was categorized as male or female. 
Nevada is comprised of 17 counties. Clark County, Washoe County, and Carson City 
make up the 3 urban areas of the state (Department of Health and Human Services 
[DHHS], 2013). In this study, geographic location was aggregated into Southern Nevada, 
Northern Nevada, or rural Nevada. Southern Nevada is comprised of Clark County. 
Northern Nevada is comprised of Washoe, Douglas, Lyon, Storey counties, and Carson 
City. The rest of the counties comprise rural Nevada (Pinheiro, Reid, Saccucci, Harris, & 
Guinan, 2012). Race/ethnicity was categorized into mutually exclusive groups as white, 
black, Hispanic, Asian/Pacific Islander, American Indian/Alaskan Native, or unknown. 
American Indians/Alaskan Natives were excluded from the survival analysis due to the 
small number of patient cases found in the dataset. Non-Hispanic whites are referred to as 
whites in this paper. Insurance status was classified as having private insurance, 
Medicare, uninsured, Medicaid, or unknown. Private insurance and Medicare patients 
were recoded into one variable. Age groups were classified as 15-44, 45-54, 55-64, 65-
74, or 75 years old and above. Civil status was classified as married, single, 
divorced/separated, or widowed. 
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Head and Neck Cancer Survival Time 
Vital status was determined from in-state death certificates. Survival time was measured 
from the date of diagnosis until December 31st, 2008 (the last date for linkage with the 
in-state death certificates), or date of death whichever came first. Cases not reported as 
dead on December 31, 2008 were censored as alive on that date. Censoring refers to 
when a subject is followed from the date of diagnosis but the event (death) is not 
observed or the subject is lost to follow-up. The overall observed survival rate is used in 
this study. 
Statistical Analysis 
Descriptive statistics were calculated, including frequency counts for each of the 
predictors, and percentages from predictor variables. 
Univariate analysis for 5-year survival rate estimates was performed using the life table, 
also known as actuarial method by race/ethnicity. We standardized for age using 
international age standards (Corazziari, Quinn, & Capocaccia, 2004). Five-year overall 
survival proportions were estimated for both males and females combined, males only, in 
Nevada, 1995-2008. These were then compared to SEER proportions for the same years. 
Kaplan Meier was used to analyze survival and plot overall survival curves. The log-rank 
test was used to compare the survival curves for significance. 
The Cox proportional hazards model was used for multivariate analysis and to estimate 
hazard ratios for survival for each of the predictors. Cox is a semi-parametric model. The 
covariates were adjusted to each other to address confounding that may result due to age, 
gender, race, insurance status, civil status, stage, site, and region. 
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Statistical analysis was performed using SPSS version 20. P-values below 0.05 were 
considered statistically significant.  
19 
 
CHAPTER 3 
RESULTS 
Patient characteristics 
There were a total of 3,091 cases of head and neck cancer in the NCCR from 1995 to 
2008. After excluding the lip, salivary glands, unknown gender, and deaths with deficient 
survival data, the total number of cases used in this study was 2,522. The characteristics 
of the study population are summarized in Appendix B. 
Univariate analysis 
Survival Rates for Each Category of the Predictor Variables 
The 5-year overall age-adjusted survival rates, for both males and females combined, by 
race in Nevada are 46.7% for white, 29.7% for black, 47.1% for Hispanic, and 46.4% for 
Asian and Pacific Islander (Table 1). The 5-year age-adjusted survival rates by race from 
SEER are 46.6% for white, 29.2% for black, 43.2% for Hispanic, and 51.2% for Asian 
and Pacific Islander (Table 2). 
 
Table 1. 5-year overall age-adjusted survival rate for males and females combined  
in Nevada, 1995-2008 
Race/ethnicity Survival Rate (%)                                   95% CI 
White 46.7 44.4 49.0 
Black 29.7 19.4 39.9 
Hispanic 47.1 36.7 57.5 
Asian/PI 46.4 34.1 58.6 
**Age standardized to Corazziari age standards 
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Table 2. 5-year overall age-adjusted survival rate for males and females combined, 
SEER, 1995-2008 
Race/ethnicity Survival Rate (%)                                   95% CI 
White 46.6 46.1 47.2 
Black 29.2 27.8 30.6 
Hispanic 43.2 41.5 45.0 
Asian/PI 51.2 49.5 52.9 
 
 
The Nevada survival rates when compared to the rates from SEER show similar survival 
rates for whites and blacks in Nevada. However, the survival rates between Hispanic and 
Asian suggest some difference compared to SEER’s Hispanic and Asian population, 
although this is not statistically significant. Hispanics in Nevada have better survival than 
Asians when compared to SEER rates which show Asians have a higher survival rate. 
To get more accurate survival rates, we separated the data by gender. The 5-year survival 
rates were calculated separately for each gender to minimize confounding from one 
another. The survival estimates for females are too unstable to report due to a small 
population sample size. After selecting cases for males only, the 5-year survival rates for 
each race in Nevada are as follows: white 44.3%, black 38.2%, Hispanic 51.0%, and 
Asian/Pacific Island 51.6% (Table 3). The SEER data revealed: white 45.3%, black 
25.7%, Hispanic 40.0%, and Asian/Pacific Island, 48.8% (Table 4).  
 
Table 3. 5-year overall age-adjusted survival rate for males in Nevada, 1995-2008 
Race/ethnicity Survival Rate (%)                                   95% CI 
White 44.3 41.5 47.1 
Black 38.2 25.8 50.6 
Hispanic 51.0 38.6 63.3 
Asian/PI 51.6 36.4 66.8 
**Age standardized to Corazziari age standards 
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Table 4. 5-year overall age-adjusted survival rate for males, SEER, 1995-2008 
Race/ethnicity Survival Rate (%)                                   95% CI 
White 45.3 44.7 46.0 
Black 25.7 24.1 27.4 
Hispanic 40.0 37.8 42.1 
Asian/PI 48.8 46.6 51.0 
 
 
Kaplan-Meier Method 
The Kaplan-Meier method was used to estimate survival and produce survival curves. 
Univariate analysis looks at one independent variable at a time to ascertain whether it 
affects survival time and whether there is significance in the survival rate of the different 
groups. Significance between Kaplan-Meier survival curves was tested using the log-rank 
test. Kaplan-Meier curves show that blacks had significantly worse overall survival than 
the other race/ethnicity groups (Figure 1). Five year survival was less than 40% for the 
group. Civil status showed that widowed cases had worse survival followed by 
divorced/separated, single, and unmarried cases (Appendix C). Univariate analysis 
suggests whether a variable is a significant independent predictor of survival but it does 
not take into account other confounding variables that may mask the true value. To 
investigate confounding variables, multivariate analysis with Cox regression was used. 
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Figure 1. Kaplan-Meier overall survival by race, 1995-2008 
 
 
Multivariate analysis 
Multivariate analysis was performed using Cox regression model. Cox regression was 
used to examine differences in survival after adjusting for other confounder variables. 
Disparities in survival with significant results were calculated and adjusted for each co-
variable (Appendix D). The reference group is the first category for each variable. 
Age 
Individuals progressively showed a higher risk of death as age increased. Individuals who 
were 75 years old and older were 3.8 times more likely to die than those who were 
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between 15 and 44 years old. Individuals who were between 65 and 74 years old were 2.6 
times more likely to die than those who were between 15 and 44 year old. Individuals 
who were between 55 and 64 years old were 1.7 times more likely to die than those who 
were between 15 and 44 years old. 
Gender 
Females had better survival than males (HR: 0.945, 95% CI: 0.83-1.08). However, this 
was not found to be significant (p=0.40). 
Site 
Oral cancer of the hypopharynx had the worse prognosis overall, with those individuals 
being 1.38 times more likely to die than those with tongue cancer (95% CI: 1.13-1.69).  
Race/Ethnicity: 
Blacks were 1.35 times more likely to die than whites (95% CI: 1.04, 1.75). 
Insurance Status: 
Uninsured individuals were 1.45 times more likely to die than those with private or 
Medicare insurance (95% CI: 1.17-1.80). 
Stage 
Individuals diagnosed at the distant stage were 2.94 times more likely to die, and regional 
stage were 1.71 times more likely to die than those diagnosed at the localized stage (95% 
CI: 2.41-3.60; 95% CI: 1.46-2.00). 
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Civil Status 
Married individuals showed better outcomes for head and neck cancer survival. Divorced 
or separated individuals were associated with the worst prognosis. Individuals who were 
divorced or separated were 1.47 times more likely to die than married individuals (95% 
CI: 1.24-1.75). 
Geographic Region 
Geographic region showed an interesting pattern but it was not found to be significant 
(p=0.10). Individuals who reside in Northern Nevada are 11% less likely to die than those 
who reside in Southern Nevada (95% CI: 0.77-1.02). 
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CHAPTER4 
DISCUSSION 
Summary of Findings 
To our knowledge this is the first study to investigate the determinants of head and neck 
cancer survival in Nevada. Publications on head and neck cancer survival in the United 
States are sparse and there is no agreement on the best set of determinants for head and 
neck cancer survival. The present study builds on previous research by examining a pool 
of potential determinants suggested by the literature. The multivariate technique was 
adopted to adjust for multiple confounding effects to determine survival outcomes for 
patients with head and neck cancer. 
1. Age, site, and stage of diagnosis 
Age, site, and stage of diagnosis are three classic determinants in cancer survival. As 
people get older, they are more likely to die as a result of the natural process of aging and 
being less tolerant to aggressive cancer treatments.  
Hypopharyngeal cancer is rare with about 3,400 cases in the United States each year 
(American Cancer Society, 2014). Hypopharyngeal cancer has one of the 
highest mortality rates of any head and neck cancer because it does not cause symptoms 
early and most of them are at an advanced stage when they are diagnosed (Piccirillo et 
al., 2007). In addition, malignant cells grow in the hypopharynx which is close to the 
cervical lymph node, increasing the risk of spreading regionally. Our study indicated that 
hypopharyngeal cancer is the most fatal subtype of head and neck cancer in Nevada. 
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Stage is the most important predictor of survival for most cancers. The sooner a cancer is 
treated, the less chance it spreads further away from the point of origin. In Nevada, the 
differences found in survival due to age and stage of diagnosis mimic the national trends 
(Pulte et al., 2010; Goldenberg, Brooksby, & Hollenbeak, 2009; and Goodwin et al., 
2008). 
2. Gender 
In general, females have better survival than males in most cancers. Surprisingly, the 
multivariate model suggested that gender is not a significant determinant for head and 
neck cancer survival in Nevada. The impact of gender on head and neck survival is not 
conclusive. Saba (2011) found no discernable difference in relative survival between 
males and females, without further analysis separated by race. 
3. Race 
Both univariate and multivariate analysis showed that there is a racial disparity in 
survival of head and neck cancer in Nevada. Similar to the national trends, blacks had 
significantly worse survival than whites based on race alone. Less than 30% of blacks 
survive five years after diagnosis, which is significantly lower than whites. The racial 
disparity in head and neck cancer survival has been well established in previous research 
(Morse et al., 2006; Goodwin et al., 2008; Moore et al., 2001). However, the degree of 
disparity varies slightly with the sample populations and study durations. The results 
from Goodwin (2008) are similar to ours, in that blacks have a lower 5-year relative 
survival rate than whites using SEER data from 1996 to 2002. Another study found a 5-
year survival rate of 51.4% for whites and 29.3% for blacks using SEER data from 1973 
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to 2008, which suggested that the survival rate for whites become worse over time while 
survival rate for blacks remain stable (Saba et al., 2011). 
Despite similar survival rates compared with the national average, black males in Nevada 
seem to survive much longer than blacks reported in SEER. Black males in Nevada have 
a 5-year survival rate of 38.2% versus a national average of 25.7%. The estimates for 
black females were suppressed due to a small sample size, but it is logical to picture a 
much lower survival rate for black females in Nevada given an overall 5-year survival 
rate of 29.7% for blacks. This finding is unique in Nevada and opposite to the literature. 
Morse et al., (2006) found that black males had the lowest 5-year survival rate at 34%, 
with black females at 52% using SEER data from 1995 to 2001. Shiboski (2007) also 
found that black females had a better 5-year survival rate of 39 percent. 
It has been reported that cancer rates among blacks in Nevada are significantly lower than 
the national average by up to 9% (Pinheiro et al., 2012). The better survival in black 
males may be attributed to the local employment opportunities, lifestyle, and culture 
endemic in Nevada, especially in Southern Nevada. The Minority Health in Nevada 2010 
report showed that poverty percentages for blacks, and whites were lower than the 
national average. The difference in per capita income by race/ethnicity between whites 
and blacks is lower in Nevada compared to other states. Additionally, 9% of blacks were 
uninsured in Nevada compared to 15% in the U.S. 
 
The Nevada Cancer Report in 2012 shows that minorities affected by cancer are more 
likely to live in areas of low economic income. Hispanics are more likely to be uninsured 
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whereas blacks are more likely to be Medicaid beneficiaries (Pinheiro et al., 2012). 
Therefore, the racial disparity in the form of 5-year survival rates might be blurred by 
other confounding variables. However, racial disparity between blacks and whites 
persists after adjusting for select confounding variables in this study. Blacks were 1.35 
times more likely to die than whites. A similar conclusion was also reached in a previous 
study (Saba et al., 2011). This highlights the urgent public health interventions needed to 
improve head and neck survival in black Nevadans. 
4. Civil status 
Civil status has been studied in cancer research which indicates that marriage, in general, 
is a protective factor in cancer incidence and associated with better survival outcomes, 
especially for married men (Wang, Wilson, Stewart, & Hollenbeak, 2011). The protective 
effect of marriage on cancer survival has been observed in most cancer studies, such as 
bladder, breast, cervical, prostate, and lung cancer (Wang et al., 2011). Aizer (2013) 
studied ten cancers including head and neck cancer, using SEER data from 2004 to 2008, 
and found that married patients were less likely to die after adjustment for covariates of 
demographics, stage, and treatment, (HR=0.80, 95% CI=0.79, 0.81). Widowed 
individuals also had lower survival versus married individuals. Head and neck cancer 
patients who were married had the greatest relative reduction in cancer death (Aizer et al., 
2013). There does not appear to be any studies that specifically address the relationship 
between civil status and survival in head and neck cancer in spite of the fact that civil 
status is conventionally included as an important covariate (Du, & Liu, 2010). The 
present study found that married individuals had significantly better survival than their 
counterparts. Overall, the worst survival was observed in divorced individuals. This result 
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differs from Aizer (2013) and Wang (2011) where single and widowed individuals have 
the worse prognosis. 
Traditionally, married individuals tend to have better prognosis when they enter cancer 
treatment after diagnosis compared to single individuals (Jatoi, 2007). We are unable to 
provide conclusive evidence on why marriage has a protective effect against cancer due 
the limitation of the study design, although this study clearly demonstrates that civil 
status is a significant determinant for head and neck cancer survival. Social behavioral 
research has demonstrated that social factors that accompany marriage can positively 
modify individuals’ behavior, such as healthy diet and lifestyle, regular screening, and 
compliance with treatment regimens, leading to improved cancer survival (Aizer et al., 
2013; and Wang et al., 2011). 
5. Geographic region  
Geographical disparities on cancer survival have been observed among regions of 
Nevada. Northern Nevada has a similar survival rate to the national average on all 
cancers combined. On the other hand, Southern Nevada, where 70% of all cancers in the 
state are diagnosed, has systematically lower survival rates (Pinheiro et al., 2012). This 
study was not able to demonstrate a significant geographic disparity on head and neck 
cancer survival between Southern and Northern Nevada, possibly due to a small sample 
size. However, our results suggested that individuals who reside in Northern Nevada had 
better head and neck survival than those who reside in Southern Nevada. 
Southern Nevada, which is comprised of only Clark County, houses 73% of the state 
population. Of this population, 40% are minorities with higher uninsured rates and lower 
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educational attainment. Minority populations who have lower education levels tend to 
have higher morbidity and mortality. The geographic disparity in Nevada may be 
partially due to the high minority population in Southern Nevada. However, the estimates 
in the present study have adjusted for race/ethnicity and insurance status. The Nevada 
Cancer Report 2012 stated that disparities in survival or prognosis for cancer in Nevada 
are more directly related to access to quality healthcare. With the School of Medicine, 
based in Reno, it is possible that Northern Nevada possesses more healthcare facilities 
and resources than Southern Nevada. Unequal quality healthcare access may be the main 
source leading to the geographic disparity in Nevada. Further research is needed to 
investigate the unequal availability of quality healthcare facilities across the state. 
6. Insurance status 
Insurance status must be taken into account to address cancer survival disparities because 
cancer treatment can be very expensive and patients often need long-term treatment and 
follow-up. Previous studies found that uninsured and Medicaid-insured patients with 
breast, cervical, colorectal, head and neck, lung, prostate or uterine cancer have lower 
survival than patients with private insurance or Medicare, even after adjustment for other 
factors (Subramanian, & Chen, 2013). The present study shows that insured individuals 
with private insurance or Medicare have significantly better chances at survival after 
diagnosis of head and neck cancer than uninsured individuals and the difference is as 
large as 50 percent. 
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Limitations 
There are limitations in this study that must be addressed.  The survival numbers in 
Nevada are very likely overestimated. Up until now, only in-state death linkages were 
performed. Other state registries, including SEER, matched their cases to both the Social 
Security Administration Master File and the National Death Linkage. Survival for 
Hispanics and Asians have to be interpreted with caution, since a proportion of these 
cases are undocumented and often impossible to match with death certificates in the 
absence of a workable social security number (Pinheiro, Morris, Liu, Bungum, & 
Altekruse, in press). The Pew Hispanic Center reports that Nevada had the highest share 
of unauthorized immigrants in the labor force with 12.2% in 2008 (Passel, & Cohn, 
2009).  A recent state report estimated that 47% of Nevadans without health insurance 
were Hispanic (DHHS, 2013). Most undocumented workers do not have insurance and 
are prone to have worse cancer survival. NCCR data used in this study are not complete. 
Data from the years 1996 to1999 were uncertified by the NPCR. Data for the years 2001 
to 2003 contained incomplete information due to deficient in-state follow-up procedures. 
By default, these cases are automatically presumed alive. Data for year 2007 contained 
incomplete information and were not certified (Pinhiero et al., 2012). In addition, risk 
factors, such as tobacco use, alcohol use, and HPV status cannot be adjusted for in this 
study due the nature of the study design. 
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Conclusions 
Cancer survival is related to a complex set of demographic and clinical factors. The 
present study showed that age, race/ethnicity, civil status, insurance status, site, stage of 
diagnosis are significant determinants for head and neck cancer survival in Nevada. 
Based on the findings of this analysis, in order to improve head and neck cancer survival 
in Nevada, I suggest the following three aspects on which public health interventions 
should focus. 
1. Reduce the racial disparity on head and neck cancer survival in Nevada 
The present study showed a significant disparity in survival due to race in Nevada. 
Blacks tend to have worse survival outcome even after adjustment for selected covariates. 
This suggests that insurance status, and socioeconomic status, may not be the solution to 
reduce disparities in survival. Other factors, such as having equal access to care, quality 
of care, better treatment options, and improved social support, may play a more 
significant role in reducing the survival disparities found in this study. Better outreach to 
inform and educate the black community about head and neck cancer survival risk factors 
and the positive effects of early screening may prevent advanced stage at diagnosis of 
HNC and lead to better survival. Reducing the number of individuals without insurance 
and increasing insurance coverage via enrollment with the newly implemented Patient 
Protection and Affordable Care Act (Obamacare), in 2014, is another avenue to 
increasing survival among blacks in Nevada. Future analysis with larger sample sizes and 
better quality data are needed to further evaluate survival disparities in the state to clarify 
the true reasons for this disparity.  
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2. Improve early diagnosis rate in Nevada 
It is important to diagnose head and neck cancer at the early stage where it is more 
treatable and results in better prognosis. Although there is no cure for head and neck 
cancer, survival rates can be greatly improved if the cancer is caught at the early stage of 
diagnosis. Increased education and outreach can improve screening rates in the minority 
population, and thereby increase their survival rates. Through implementation of the 
Patient Protection and Affordable Care Act, more uninsured minorities in this state 
should be encouraged to apply for insurance coverage and reduce the disparity found in 
access to care. 
3. Create equal access to quality healthcare across the state of Nevada  
The present study suggested a geographic disparity in survival is starting to emerge 
between Northern and Southern Nevada. Although geographic region was not shown to 
be significant in this study, there is a suggestion that shows Northern Nevada to have 
better survival outcomes than Southern Nevada where most of the state population 
resides. A future study with a larger sample size may show that a statistically significant 
geographic disparity exists between the North and South for head and neck cancer. 
Quality of care may be an issue between Southern and Northern Nevada. Over 70% of 
the population live in the south but the state’s only medical school remains in Reno, 
Nevada. Medical schools often attract more doctors, researchers, and clinics to local 
areas. As a result, they provide better quality of care to the local population due to having 
a larger supply of skilled professionals and bringing in more research money into the 
local economy which attracts more health professionals. Currently, Northern Nevada 
possesses more healthcare resources with possibly more ease at access. For example, the 
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2008 Nevada legislature found that Southern Nevada had 530 registered nurses per 
100,000 population while Northern Nevada had 702 registered nurses per 100,000 
population. Access to care is a contributing factor to better survival. Northern Nevada 
may have more public transportation options available to local residents than Southern 
Nevada. Cancer patients with inadequate transportation may miss more appointments 
with health professionals or miss filling their prescriptions in a timely manner. Fewer 
medical specialists may be located in the large urban areas of Southern Nevada compared 
to Northern Nevada. Since Southern Nevada’s population is more diverse with a larger 
population than Northern Nevada, more resources should be proportionately diverted to 
the region to reduce the survival disparity seen between the two geographic regions. 
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APPENDIX A. INSTITUTIONAL REVIEW BOARD APPROVAL 
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APPENDIX B. CHARACTERISTICS AMONG 2,522 PATIENTS WITH HEAD AND 
NECK CANCER 
 
Variable   No. % 
Region    
  Southern 1760 69.8 
 Northern 602 23.9 
  Rural 160 6.3 
Tumor location   
  Tongue 899 35.6 
 Floor of mouth 232 9.2 
  Gums/other 341 13.5 
 Nasopharynx 160 6.3 
  Tonsil 421 16.7 
 Oropharynx 139 5.5 
  Hypopharynx 206 8.2 
 Other 124 4.9 
Race/ethnicity   
  White 2164 85.8 
 Black 103 4.1 
  Hispanic 114 4.5 
 Asian 86 3.4 
  AI/AN 13 0.5 
 Unknown 42 1.7 
Insurance status   
  Private/Medicare 1680 66.6 
 Uninsured 178 7.1 
  Medicaid 112 4.4 
 Unknown 552 21.9 
Age group (years)   
  15-44 178 7.1 
 45-54 493 19.5 
  55-64 786 31.2 
 65-74 676 26.8 
  75+ 389 15.4 
Stage    
  Local 709 28.1 
 Regional 1035 41.0 
  Distant 287 11.4 
 Unknown 491 19.5 
Civil status   
  Married 1194 47.3 
 Single 439 17.4 
  Divorced/Separated 327 13.0 
 Widowed 263 10.4 
  Unknown 297 11.8 
Gender    
  Male 1750 69.4 
  Female 772 30.6 
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APPENDIX C. KAPLAN-MEIER OVERALL SURVIVAL BY CIVIL STATUS, 1995-
2008 
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APPENDIX D. COX HAZARD RATIOS (HR), HEAD AND NECK CANCER 
SURVIVAL, IN NEVADA, 1995-2008 
 
 
Variable N HR 95% CI p-value 
Region           
 Southern 1760 Ref - - - 
 Northern 602 0.89 0.77 1.02 0.10 
 Rural 160 1.08 0.86 1.36 0.50 
Gender       
 Male 1750 Ref - - - 
 Female 772 0.95 0.83 1.08 0.40 
Tumor location       
 Tongue 899 Ref - - - 
 Floor of mouth 232 1.15 0.94 1.41 0.18 
 Gums 341 0.94 0.78 1.13 0.53 
 Nasopharynx 160 0.99 0.77 1.27 0.93 
 Tonsil 421 0.88 0.73 1.05 0.16 
 Oropharynx 139 0.93 0.72 1.20 0.57 
 Hypopharynx 206 1.38 1.13 1.69 <0.001 
 Other 124 0.97 0.76 1.25 0.83 
Race/ethnicity       
 White 2164 Ref - - - 
 Black 103 1.35 1.04 1.75 0.02 
 Hispanic 114 0.93 0.70 1.23 0.59 
 Asian/PI 86 1.14 0.82 1.60 0.44 
 Unknown 42 0.23 0.10 0.57 <0.001 
Insurance status       
 Private/Medicare 1680 Ref - - - 
 Uninsured 178 1.45 1.17 1.80 <0.001 
 Medicaid 112 1.21 0.91 1.62 0.20 
 Unknown 552 1.25 1.05 1.49 0.01 
Age group (years)       
 15-44 178 Ref - - - 
 45-54 493 1.32 0.97 1.79 0.08 
 55-64 786 1.69 1.26 2.26 <0.001 
 65-74 676 2.63 1.94 3.57 <0.001 
 75+ 389 3.87 2.81 5.33 <0.001 
Stage       
 Local 709 Ref - - - 
 Regional 1035 1.71 1.46 2.00 <0.001 
 Distant 287 2.94 2.41 3.59 <0.001 
 Unknown 491 2.14 1.79 2.56 <0.001 
Civil status       
 Married 1194 Ref - - - 
 Single 439 1.23 1.05 1.45 0.01 
 Divorced/Separated 327 1.47 1.24 1.75 <0.001 
 Widowed 263 1.38 1.15 1.66 <0.001 
 Unknown 297 0.77 0.62 0.95 0.02 
 Abbreviations: Ref, reference; HR, hazard ratio. 
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